Related Experiment Video
Updated: Jul 25, 2025

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
Published on: April 3, 2018
PKR-NF-κB Pathway Upstream of IFN-β Induction Is Dysregulated in Oncolytic Sindbis Virus-infected HeLa Cells
Xue Ma1, Tomoko Ogawa1, Zheng Tian1
1Department of Molecular Virology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Background/Aim:
Sindbis virus (SINV) is a naturally occurring oncolytic virus that kills cancer cells and is less harmful to normal cells. In this study, a recombinant SINV, which expressed green and blue fluorescent proteins, was used to precisely analyze SINV infection and replication.
Materials And Methods:
Antiviral responses, including IFN-β mRNA, protein kinase R (PKR), NF-B, and caspase 3/7, were analyzed in SINV-infected cancerous HeLa cells and normal human fibroblast TIG-1-20 cells.
Results:
SINV could infect, replicate, and proliferate both in HeLa and TIG-1-20 cells, causing lytic infection only in HeLa cells. SINV grew preferentially in HeLa cells causing remarkable apoptosis. IFN-β mRNA expression was suppressed in SINV-infected HeLa cells compared to that in TIG-1-20 cells. Further analyses of PKR and NF-B upstream of IFN-β induction revealed that the compromised response in the PKR-NF-B pathway during early infection coincided with IFN induction suppression in HeLa cells.
Conclusion:
Dysregulation of PKR in HeLa cells is the determinant of SINV oncolysis.
Insights
Sindbis virus (SINV) effectively infects cancer cells, causing apoptosis. Dysregulation of protein kinase R (PKR) in cancer cells determines the oncolytic effect of SINV, making it a promising cancer therapy.
Area of Science:
- Virology
- Cancer Biology
- Immunology
Background:
- Sindbis virus (SINV) is a naturally occurring oncolytic virus with selective toxicity towards cancer cells.
- Recombinant SINV expressing fluorescent proteins enables precise analysis of viral infection and replication dynamics.
Purpose of the Study:
- To precisely analyze the infection and replication of a recombinant Sindbis virus (SINV) in both cancerous and normal cells.
- To investigate the antiviral responses in cancer cells versus normal cells upon SINV infection.
Main Methods:
- Analysis of antiviral responses, including Interferon-beta (IFN-β) mRNA, protein kinase R (PKR), Nuclear Factor-kappa B (NF-κB), and caspase 3/7.
- Comparative study of SINV infection in cancerous HeLa cells and normal human fibroblast TIG-1-20 cells.
Main Results:
- SINV infected, replicated, and proliferated in both HeLa and TIG-1-20 cells, but caused lytic infection and apoptosis exclusively in HeLa cells.
- IFN-β mRNA expression was suppressed in SINV-infected HeLa cells compared to TIG-1-20 cells.
- Compromised PKR and NF-κB pathway activation in early infection of HeLa cells correlated with suppressed IFN induction.
Conclusions:
- The dysregulation of protein kinase R (PKR) in HeLa cells is the key determinant for Sindbis virus (SINV) oncolysis.
- SINV demonstrates potential as an oncolytic agent due to its preferential replication and induction of apoptosis in cancer cells.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
Inhibition of Cdk Activity
MAPK Signaling Cascades

